Privo Technologies Completes Phase 2 Run-In for PRV111 Oral Cancer Patch
PEABODY, Mass., Oct. 14, 2025 — Privo Technologies, Inc., a clinical-stage biopharmaceutical company pioneering localized cancer therapies, announced the...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Technology for New Therapy
PEABODY, Mass., Oct. 14, 2025 — Privo Technologies, Inc., a clinical-stage biopharmaceutical company pioneering localized cancer therapies, announced the...
ANN ARBOR, Mich. – October 10, 2025 – Kraig Biocraft Laboratories, Inc. has announced a selective breeding advancement that...
LONDON, Oct. 8, 2025 — Haleon, the world’s largest pure-play consumer health company, has partnered with Salesforce to deploy...
OTTAWA, Oct. 2, 2025 — Kinaxis announced that Sobi, a specialist in rare‐disease biopharma, will adopt the Kinaxis Maestro®...
September 17, 2025 — Columbia, S.C., ALLT.AI has introduced a new generation of large language models (LLMs) that draw...
ESSEN/MUNICH, Germany, September 9, 2025 – Evonik and Ethris have entered a strategic partnership to enhance RNA-based therapeutic solutions...
Veeva Systems (NYSE: VEEV) today announced a strategic collaboration with global biotechnology leader Amgen to drive innovation in clinical...
SmartLabs and Sonrai Analytics today announced a global strategic alliance to integrate Sonrai’s next-generation AI platform, Sonrai Discovery, into...
EVERSANA and Waltz Health announced a merger today to form a unified healthcare platform designed to redefine pharmaceutical commercialization...
Research Triangle Park, NC & Pleasanton, CA – August 20, 2025 – After years of high-profile legal battles, life...
